Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 11, 2010, Pages 1466-1473

  Yener, Gülgün ^a   Üner, Melike ^a   Gönüllü, Ümit ^a   Yildirim, Sinem ^a   Kiliç, Pinar ^a   Aslan, Serap Saǧlik ^a   Barla, Asli ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b

^c Turkey

Author keywords

Anti inflammatory activity; Lornoxicam; Meloxicam; Transdermal delivery; Transdermal patch

Indexed keywords

CARBOXYMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; LORNOXICAM; MELOXICAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG SYNTHESIS; EX VIVO STUDY; EXCIPIENT COMPATIBILITY; IN VIVO STUDY; MOLECULAR WEIGHT; NONHUMAN; PAW EDEMA; PHYSICAL CHEMISTRY; RAT; SKIN PENETRATION; TENSILE STRENGTH; THICKNESS; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG DELIVERY SYSTEMS; EDEMA; METHYLCELLULOSE; PIROXICAM; RATS; RATS, WISTAR; SKIN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TENSILE STRENGTH; THIAZINES; THIAZOLES;

EID: 78049478380     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.1466     Document Type: Article

References (27)

1. Turner P., Johnston A., Postgrad. Med. J., 66, 28-29 (1990).
2. Balfour J. A., Fitton A., Barradell L. B., Drugs, 51, 639-657 (1996).
3. Meineke I., Turck D., Br. J. Clin. Pharmacol., 55, 32-38 (2003).
4. Olkkola K. T., Brunetto A. V., Mattila M. J., Clin. Pharmacokinet., 26, 107-120 (1994).
5. Aronson J. K., "Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions," Elsevier, Amsterdam, 2006, pp. 2167-2168.
6. Aronson J. K., "Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions," Elsevier, Amsterdam, 2006, pp. 2248-2249.
7. Yakhno N., Guekht A., Skoromets A., Spirin N., Strachunskaya E., Ternavsky A., Olsen K. J., Moller P. L., Clin. Drug Investig., 26, 267-277 (2006).
8. Baker R. W., Heller J., "Materials Selection for Transdermal Delivery Systems," STS Publishing, U.K., 1992.
9. Williams A. C., "Transdermal and Topical Drug Delivery- From Theory to Clinical Practice," Pharmaceutical Press, London, 2003.
10. Kiliç P., "Meloksikam ve Lornoksikam Içeren Topikal Formülasyonlar Üzerine Çalişmalar," M. Sc., Thesis. Istanbul University, Istanbul, 2008.
11. Rao P. R., Diwan P. V., Pharm. Acta Helv., 72, 47-51 (1997).
12. Korsmeyer R. W., Gurny R., Doelker E., Buri P., Peppas N. A., Int. J. Pharm., 15, 25-35 (1983).
13. Ritschel W. A., "Drug Delivery Devices, Fundamentals and Applications," ed. by Tyle P., Marcel Dekker, New York, 1988.
14. Stott O. W., Williams A. C., Barry B. W., J. Controlled Release, 50, 297-308 (1998).
15. Ford J. L., Timmins P., "Pharmaceutical Thermal Analysis," Ellis Horwood, Chichester, 1989.
16. Teeranachaideekul V., Müller R. H., Junyaprasert V. B., Int. J. Pharm., 340, 198-206 (2007).
17. Kibbe A., "Handbook of Pharmaceutical Excipients," American Pharmaceutical Assocciation and Pharmaceutical Press, New York, 2000.
18. Siepmann J., Peppas N. A., Adv. Drug Deliv. Rev., 48, 139-157 (2001).
19. Guyot M., Fawaz F., Int. J. Pharm., 204, 171-182 (2000).
20. Galani A., Demertzis M. A., Kubicki M., Kovala-Demertzi D., Eur. J. Inorg. Chem., 2003, 1761-1767 (2003).
21. Oliveira E. F. S., Azevedo R. C. P., Bonfilio R., Oliveira D. B., Ribeiro G. P., Araujo M. B., Brazil. J. Pharm. Sci., 45, 67-73 (2009).
22. Hadgraft J., Wolff M., "Dermal and Transdermal Drug Delivery," ed. by Gurny R., Teubner A., Wissenschaftliche Verlagsgesellschaft, Stuttgart, 1993, pp. 161-172.
23. Beetge E., du Plessis J., Müller D.G., Goosen C., van Rensburg F. J., Int. J. Pharm., 193, 261-264 (2000).
24. "The Merck Index," 14th ed., Merck and Co., Inc., U.S.A., 2006.
25. Goosen C., du Plessis J., Müller D. G., van Rensburg L. F. J., Int. J. Pharm., 163, 203-209 (1998).
26. Prasad Byrav D. S., Medhi B., Prakash A., Patyar S., Wadhwa S., Drug Rev., 20, 27-31 (2009).
27. Snor W., Liedl E., Weiss-Greiler P., Viernstein H., Wolschann P., Int. J. Pharm., 381, 146-152 (2009).